Theravance Biopharma Aktie
9,35
EUR
-0,10
EUR
-1,06
%
11,05
USD
-0,07
USD
-0,65
%
Werbung
Theravance Biopharma Aktie Analyse
16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC |
Werbung
Werbung